{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:05:16Z","timestamp":1773140716327,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s40121-022-00745-2","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T10:04:42Z","timestamp":1671098682000},"page":"303-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-2554","authenticated-orcid":false,"given":"Tom\u00e1s Jos\u00e9","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abelardo","family":"B\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Bernardo-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Bernat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Canaro-Hirnyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Entrena-Ure\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Fern\u00e1ndez-Fuertes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Guinea de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyes","family":"Jim\u00e9nez-B\u00e1rcenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Pascual-Izquierdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5673-4490","authenticated-orcid":false,"given":"Isidro","family":"Jarque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"issue":"4","key":"745_CR1","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.4269\/ajtmh.20-1536","volume":"104","author":"A Rahman","year":"2021","unstructured":"Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological abnormalities in COVID-19: a narrative review. Am J Trop Med Hyg. 2021;104(4):1188\u2013201.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"745_CR2","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1002\/ajh.25774","volume":"95","author":"BE Fan","year":"2020","unstructured":"Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et\u00a0al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol. 2020;95(6):E131\u20134.","journal-title":"Am J Hematol"},{"key":"745_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","volume":"506","author":"G Lippi","year":"2020","unstructured":"Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clin Chim Acta. 2020;506:145\u20138.","journal-title":"Clin Chim Acta"},{"key":"745_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.thromres.2020.06.008","volume":"193","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zeng X, Jiao Y, Li Z, Liu Q, Ye J, et\u00a0al. Mechanisms involved in the development of thrombocytopenia in patients with COVID-19. Thromb Res. 2020;193:110\u20135.","journal-title":"Thromb Res"},{"issue":"2","key":"745_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/17474086.2022.2029699","volume":"15","author":"MG Alharbi","year":"2022","unstructured":"Alharbi MG, Alanazi N, Yousef A, Alanazi N, Alotaibi B, Aljurf M, et\u00a0al. COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis. Expert Rev Hematol. 2022;15(2):157\u201366.","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"745_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/09537104.2022.2042237","volume":"33","author":"SC Chou","year":"2022","unstructured":"Chou SC, Chang YC, Liao CK, Chen TC, Sun KJ, Huang WH, et\u00a0al. New presentations and exacerbations of immune thrombocytopenia after coronavirus disease 2019 vaccinations: the Taiwan experience. Platelets. 2022;33(4):531\u20135.","journal-title":"Platelets"},{"issue":"1","key":"745_CR7","doi-asserted-by":"publisher","first-page":"e24064","DOI":"10.1002\/jcla.24064","volume":"36","author":"EAKD Al-Saadi","year":"2022","unstructured":"Al-Saadi EAKD, Abdulnabi MA. Hematological changes associated with COVID-19 infection. J Clin Lab Anal. 2022;36(1):e24064.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"745_CR8","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/jcm11041088","volume":"11","author":"M Mocan","year":"2022","unstructured":"Mocan M, Chiorescu RM, Tirnovan A, Buksa BS, Farca AD. Severe thrombocytopenia as a manifestation of COVID-19 infection. J Clin Med. 2022;11(4):1088.","journal-title":"J Clin Med"},{"issue":"6","key":"745_CR9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/17474086.2022.2080051","volume":"15","author":"S Alahyari","year":"2022","unstructured":"Alahyari S, Moradi M, Rajaeinejad M, Jalaeikhoo H. Post-COVID-19 hematologic complications: a systematic review. Expert Rev Hematol. 2022;15(6):539\u201346.","journal-title":"Expert Rev Hematol"},{"issue":"1","key":"745_CR10","first-page":"1","volume":"38","author":"E Prompetchara","year":"2020","unstructured":"Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020;38(1):1\u20139.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"3","key":"745_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12250-020-00207-4","volume":"35","author":"Y Fu","year":"2020","unstructured":"Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin. 2020;35(3):266\u201371.","journal-title":"Virol Sin"},{"issue":"6","key":"745_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00277-020-04019-0","volume":"99","author":"P Xu","year":"2020","unstructured":"Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205\u20138.","journal-title":"Ann Hematol"},{"issue":"2","key":"745_CR13","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00277-020-04366-y","volume":"100","author":"MS Rahi","year":"2021","unstructured":"Rahi MS, Jindal V, Reyes SP, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol. 2021;100(2):309\u201320.","journal-title":"Ann Hematol"},{"issue":"1","key":"745_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27452","volume":"66","author":"P Giordano","year":"2019","unstructured":"Giordano P, Urbano F, Lassandro G, Bianchi FP, Tolva A, Saracco P, et\u00a0al. Role of antithyroid autoimmunity as a predictive biomarker of chronic immune thrombocytopenia. Pediatr Blood Cancer. 2019;66(1): e27452.","journal-title":"Pediatr Blood Cancer"},{"issue":"22","key":"745_CR15","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, et\u00a0al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3(22):3780\u2013817.","journal-title":"Blood Adv"},{"issue":"23","key":"745_CR16","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et\u00a0al. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829\u201366.","journal-title":"Blood Adv"},{"issue":"1","key":"745_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5694\/mja2.51284","volume":"216","author":"PY Choi","year":"2022","unstructured":"Choi PY, Merriman E, Bennett A, Enjeti AK, Tan CW, Goncalves I, et\u00a0al. Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand. Med J Aust. 2022;216(1):43\u201352.","journal-title":"Med J Aust"},{"issue":"3","key":"745_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/bjh.17506","volume":"194","author":"ME Mingot-Castellano","year":"2021","unstructured":"Mingot-Castellano ME, Alcalde-Mellado P, Pascual-Izquierdo C, Perez Rus G, Calo P\u00e9rez A, Martinez MP, et\u00a0al. Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain. Br J Haematol. 2021;194(3):537\u201341.","journal-title":"Br J Haematol"},{"issue":"2","key":"745_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/jha2.406","volume":"3","author":"G Lapietra","year":"2022","unstructured":"Lapietra G, Ferretti A, Baldacci E, Chistolini A, Santoro C. Immune thrombocytopenia management during COVID-19 pandemic: an Italian monocentric experience. EJHaem. 2022;3(2):453\u20136.","journal-title":"EJHaem"},{"issue":"1","key":"745_CR20","first-page":"41","volume":"30","author":"M Bahadoram","year":"2022","unstructured":"Bahadoram M, Saeedi-Boroujeni A, Mahmoudian-Sani MR, Hussaini H, Hassanzadeh S. COVID-19-induced immune thrombocytopenic purpura Immunopathogenesis and clinical implications. Infez Med. 2022;30(1):41\u201350.","journal-title":"Infez Med"},{"issue":"11","key":"745_CR21","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1182\/blood-2013-04-494096","volume":"122","author":"I Nazi","year":"2013","unstructured":"Nazi I, Kelton JG, Larch\u00e9 M, Snider DP, Heddle NM, Crowther MA, et\u00a0al. The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 2013;122(11):1946\u201353.","journal-title":"Blood"},{"issue":"6","key":"745_CR22","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/bjh.16775","volume":"189","author":"S Pavord","year":"2020","unstructured":"Pavord S, Thachil J, Hunt BJ, Murphy M, Lowe G, Laffan M, et\u00a0al. Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic. Br J Haematol. 2020;189(6):1038\u201343.","journal-title":"Br J Haematol"},{"issue":"2","key":"745_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/bjh.17804","volume":"196","author":"A Rampotas","year":"2022","unstructured":"Rampotas A, Watson E, Burton K, Hill QA, Pavord S. A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK. Br J Haematol. 2022;196(2):351\u20135.","journal-title":"Br J Haematol"},{"issue":"4","key":"745_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2141.2006.06024.x","volume":"133","author":"N Cooper","year":"2006","unstructured":"Cooper N, Bussel J. The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol. 2006;133(4):364\u201374.","journal-title":"Br J Haematol"},{"issue":"10","key":"745_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","volume":"20","author":"M Jeyanathan","year":"2020","unstructured":"Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20(10):615\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"745_CR26","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/ajh.26132","volume":"96","author":"EJ Lee","year":"2021","unstructured":"Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, et\u00a0al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021;96(5):534\u20137.","journal-title":"Am J Hematol"},{"issue":"25","key":"745_CR27","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1016\/j.vaccine.2021.04.054","volume":"39","author":"KJ Welsh","year":"2021","unstructured":"Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2021;39(25):3329\u201332.","journal-title":"Vaccine"},{"issue":"27","key":"745_CR28","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et\u00a0al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"3","key":"745_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa2107456","volume":"385","author":"RW Frenck Jr","year":"2021","unstructured":"Frenck RW Jr, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, et\u00a0al. Safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents. N Engl J Med. 2021;385(3):239\u201350.","journal-title":"N Engl J Med"},{"issue":"19","key":"745_CR30","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","volume":"385","author":"SJ Thomas","year":"2021","unstructured":"Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, Lockhart S, et\u00a0al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months. N Engl J Med. 2021;385(19):1761\u201373.","journal-title":"N Engl J Med"},{"issue":"20","key":"745_CR31","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJMoa2200674","volume":"386","author":"ED Moreira Jr","year":"2022","unstructured":"Moreira ED Jr, Kitchin N, Xu X, Dychter SS, Lockhart S, Gurtman A, et\u00a0al. Safety and efficacy of a third dose of BNT162b2 COVID-19 vaccine. N Engl J Med. 2022;386(20):1910\u201321.","journal-title":"N Engl J Med"},{"issue":"12","key":"745_CR32","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","volume":"385","author":"N Barda","year":"2021","unstructured":"Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et\u00a0al. Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078\u201390.","journal-title":"N Engl J Med"},{"key":"745_CR33","unstructured":"Arellano JLP (2020) Cap\u00edtulo 14: mecanismos inmunol\u00f3gicos de la enfermedad (III): Tolerancia a los ant\u00edgenos propios, Autoinmunidad. En: Sisinio de Castro. Manual de Patolog\u00eda general.\u00a08\u00aa edition,\u00a92020 Elsevier Espa\u00f1a, S.L.U. ISBN: 978-84-9113-123-6. eISBN: 978-84-9113-162-5."},{"issue":"1","key":"745_CR34","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1016\/S2352-3026(21)00306-9","volume":"9","author":"FA Klok","year":"2022","unstructured":"Klok FA, Pai M, Huisman MV, Makris M. Vaccine-induced immune thrombotic thrombocytopenia. Lancet Haematol. 2022;9(1):e73\u201380.","journal-title":"Lancet Haematol"},{"issue":"2","key":"745_CR35","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s11845-021-02614-2","volume":"191","author":"V Saudagar","year":"2022","unstructured":"Saudagar V, Patil S, Goh S, Pothiawala S. Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine. Ir J Med Sci. 2022;191(2):919\u201320.","journal-title":"Ir J Med Sci"},{"key":"745_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.thromres.2021.12.002","volume":"209","author":"Y Liu","year":"2022","unstructured":"Liu Y, Shao Z, Wang H. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. Thromb Res. 2022;209:75\u20139.","journal-title":"Thromb Res"},{"issue":"5","key":"745_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tcm.2022.02.008","volume":"32","author":"T Iba","year":"2022","unstructured":"Iba T, Levy JH. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. Trends Cardiovasc Med. 2022;32(5):249\u201356.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"745_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/atm.atm_404_21","volume":"17","author":"M Sarkar","year":"2022","unstructured":"Sarkar M, Madabhavi IV, Quy PN, Govindagoudar MB. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review. Ann Thorac Med. 2022;17(1):1\u201313.","journal-title":"Ann Thorac Med"},{"issue":"12","key":"745_CR39","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood.2021014214","volume":"139","author":"L Sch\u00f6nborn","year":"2022","unstructured":"Sch\u00f6nborn L, Thiele T, Kaderali L, G\u00fcnther A, Hoffmann T, Seck SE, et\u00a0al. Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient. Blood. 2022;139(12):1903\u20137.","journal-title":"Blood"},{"issue":"3","key":"745_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00277-021-04584-y","volume":"101","author":"J Ruhe","year":"2022","unstructured":"Ruhe J, Schnetzke U, Kentouche K, Prims F, Baier M, Herfurth K, et\u00a0al. Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine. Ann Hematol. 2022;101(3):717\u20139.","journal-title":"Ann Hematol"},{"issue":"3","key":"745_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2169\/internalmedicine.8568-21","volume":"61","author":"K Yoshida","year":"2022","unstructured":"Yoshida K, Sakaki A, Matsuyama Y, Mushino T, Matsumoto M, Sonoki T, et\u00a0al. Acquired thrombotic thrombocytopenic purpura following BNT162b2 mRNA coronavirus disease vaccination in a Japanese patient. Intern Med. 2022;61(3):407\u201312.","journal-title":"Intern Med"},{"issue":"1","key":"745_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12658","volume":"6","author":"W Deucher","year":"2022","unstructured":"Deucher W, Sukumar S, Cataland SR. Clinical relapse of immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination. Res Pract Thromb Haemost. 2022;6(1): e12658.","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"745_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2021.103145","volume":"60","author":"C Sissa","year":"2021","unstructured":"Sissa C, Al-Khaffaf A, Frattini F, Gaiardoni R, Mimiola E, Montorsi P, et\u00a0al. Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine. Transfus Apher Sci. 2021;60(4): 103145.","journal-title":"Transfus Apher Sci"},{"key":"745_CR44","doi-asserted-by":"crossref","unstructured":"Tso ACY, Ong KH, Sum CLL, Fan BE, Chan GYL, Christopher D, et\u00a0al. Acquired thrombotic Thrombocytopenic purpura: a rare coincidence after COVID-19 mRNA vaccine? Semin Thromb Hemost. 2022.","DOI":"10.1055\/s-0042-1744301"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00745-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-022-00745-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00745-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T05:48:26Z","timestamp":1676353706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-022-00745-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1007\/s40121-022-00745-2","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"2 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}